Drug-related problems and changes in drug utilization after medication reviews in nursing homes in Oslo, Norway

References

• Halvorsen KH, Ruths S, Granas AG, et al. Multidisciplinary intervention to identify and resolve drug-related problems in Norwegian nursing homes. Scand J Prim Health Care. 2010;28:82–88.
   PubMed Web of Science ®Google Scholar
• Selbaek G, Kirkevold O, Engedal K. The prevalence of psychiatric symptoms and behavioral disturbances and the use of psychotropic drugs in Norwegian nursing homes. Int J Geriat Psychiatry. 2007;22:843–849.
   PubMed Web of Science ®Google Scholar
• Vossius C, Selbaek G, Ystebø AE, et al. Ressursbruk og sykdomsforløp ved demens [Resource use and disease course in dementia] 2015.
   Google Scholar
• Soraas IA, Staurset HB, Slordal L, et al. Legemiddelinteraksjoner hos pasienter i sykehjem [Drug-drug interactions in nursing home patients]. Tidsskr nor Laegeforen. 2014;134:1041–1046.
   PubMedGoogle Scholar
• Onder G, Liperoti R, Fialova D, et al. Polypharmacy in nursing home in Europe: results from the SHELTER study. J Gerontol A Biol Sci Med Sci. 2012;67:698–704.
   PubMed Web of Science ®Google Scholar
• Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13:57–65.
   PubMed Web of Science ®Google Scholar
• Mangoni AA, Jackson SHD. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2003;57:6–14.
   Web of Science ®Google Scholar
• Ruths S, Viktil KK, Blix HS. Klassifisering av legemiddelrelaterte problemer [Classification of drug-related problems]. Tidsskr nor Laegeforen. 2007;127:3073–3076.
   PubMedGoogle Scholar
• Interaksjonsdatabase for norske klinikere FEST (tidligere DRUID) [Drug-drug interaction database for Norwegian clinicians (previous DRUID database)] [Internet]. 2017 [cited 2017 Jan 20]. Available from: http://www.interaksjoner.no.
   Google Scholar
• Gallagher P, Ryan C, Byrne S, et al. STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46:72–83.
   PubMed Web of Science ®Google Scholar
• Rognstad S, Brekke M, Fetveit A, et al. The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients. A modified Delphi study. Scand J Prim Health Care. 2009;27:153–159.
   PubMed Web of Science ®Google Scholar
• Ruths S, Straand J, Nygaard HA. Multidisciplinary medication review in nursing home residents: what are the most significant drug-related problems? The Bergen District Nursing Home (BEDNURS) study. Qual Saf Health Care. 2003;12:176–180.
   PubMedGoogle Scholar
• Davidsson M, Vibe OE, Ruths S, et al. A multidisciplinary approach to improve drug therapy in nursing homes. J Multidiscip Healthc. 2011;4:9–13.
   PubMedGoogle Scholar
• Helsedirektoratet. Veileder om legemiddelgjennomganger (IS-1998). Oslo: Helsedirektoratet; 2015. [cited 18 Jan 2017]. Available from: https://helsedirektoratet.no.
   Google Scholar
• Alldred DP, Kennedy MC, Hughes C, et al. Interventions to optimise prescribing for older people in care homes. Cochrane Database Syst Rev. 2016;2:CD009095.
   PubMed Web of Science ®Google Scholar
• Brulhart MI, Wermeille JP. Multidisciplinary medication review: evaluation of a pharmaceutical care model for nursing homes. Int J Clin Pharm. 2011;33:549–557.
   PubMed Web of Science ®Google Scholar
• Furniss L, Burns A, Craig SKL, et al. Effects of a pharmacist's medication review in nursing homes. Randomised controlled trial. Br J Psychiatry. 2000;176:563–567.
   PubMed Web of Science ®Google Scholar
• Finkers F, Maring JG, Boersma F, et al. A study of medication reviews to identify drug-related problems of polypharmacy patients in the Dutch nursing home setting. J Clin Pharm Ther. 2007;32:469–476.
   PubMed Web of Science ®Google Scholar
• WHO Collaborating Center for Drug Statistics Methodology. [Internet]. Guidelines for ATC classification and DDD assignment Oslo. 2015. Available from: http://www.whocc.no/.
   Google Scholar
• Krüger K, Folkestad M, Geitung JT, et al. Psychoactive drugs in seven nursing homes. Prim Health Care Res Dev. 2012;13:244–254.
   PubMedGoogle Scholar
• Ruths S, Sorensen PH, Kirkevold O, et al. Trends in psychotropic drug prescribing in Norwegian nursing homes from 1997 to 2009: a comparison of six cohorts. Int J Geriatr Psychiatry. 2013;28:868–876.
   PubMed Web of Science ®Google Scholar
• Sandvik R, Selbaek G, Kirkevold O, et al. Analgesic prescribing patterns in Norwegian nursing homes from 2000 to 2011: trend analyses of four data samples. Age Ageing. 2016;45:54–60.
   PubMed Web of Science ®Google Scholar
• Nyborg G, Straand J, Klovning A, et al. The Norwegian General Practice – Nursing Home criteria (NORGEP-NH) for potentially inappropriate medication use: A web-based Delphi study. Scand J Prim Health Care. 2015; 33:134–141.
   PubMed Web of Science ®Google Scholar
• Olsson J, Bergman A, Carlsten A, et al. Quality of drug prescribing in elderly people in nursing homes and special care units for dementia: a cross-sectional computerized pharmacy register analysis. Clin Drug Investig. 2010;30:289–300.
   PubMed Web of Science ®Google Scholar
• Hosia-Randell HM, Muurinen SM, Pitkala KH. Exposure to potentially inappropriate drugs and drug-drug interactions in elderly nursing home residents in Helsinki, Finland: a cross-sectional study. Drugs Aging. 2008;25:683–692.
   PubMed Web of Science ®Google Scholar
• Husebo BS, Ballard C, Sandvik R, et al. Efficacy of treating pain to reduce behavioral disturbances in residents of nursing homes with dementia: cluster randomized clinical trial. BMJ. 2011;343:d4065.
   PubMed Web of Science ®Google Scholar
• Iden KR, Hjorleifsson S, Ruths S. Treatment decisions on antidepressants in nursing homes: a qualitative study. Scand J Prim Health Care. 2011;29:252–256.
   PubMed Web of Science ®Google Scholar
• Ruths S, Straand J, Nygaard HA, et al. Stopping antipsychotic drug therapy in demented nursing home patients: a randomized, placebo-controlled study–the Bergen District Nursing Home Study (BEDNURS). Int J Geriat Psychiatry. 2008;23:889–895.
   PubMed Web of Science ®Google Scholar
• Bergh S, Selbaek G, Engedal K. Discontinuation of antidepressants in people with dementia and neuropsychiatric symptoms (DESEP study): double blind, randomised, parallel group, placebo controlled trial. BMJ. 2012;344:e1566.
   PubMed Web of Science ®Google Scholar
• Tampi RR, Tampi DJ. Efficacy and tolerability of benzodiazepines for the treatment of behavioral and psychological symptoms of dementia: a systematic review of randomized controlled trials. Am J Alzheimers Dis Other Demen. 2014;29:565–574.
   PubMed Web of Science ®Google Scholar